-
Categories
-
Technology, Other, Financial Services, Healthcare & Medical, Consumer Goods & Products
-
Min Investment
-
$100
Key Deal Facts
Signed contracts for $5.5M in projected revenue
1,000+ patients treated and 12,000 patients on the waitlist
2 out of 3 users report ZERO asthma attacks or COPD flare ups within 6 months
13 patents allowed with 10 more pending - a robust patent portfolio
FDA 510(k) clearance pathway & covered under existing reimbursement codes
Led by healthtech executives from Lark Health ($1B valuation) & Blue Cross (100M+ members)
Forecasting $35M+ in revenue in the next 2 years (not guaranteed)
Backed by leading venture funds Safar Partners & Chloe Capital
Management Team / Advisory Board Bios
VC-Backed
Raised $250K or more from a venture firm, Sharon Samjitsingh CEO & Co-FounderHealthtech disruptor. Drove 20X revenue growth & led $150M portfolio at $7B conglomerate. Top 100 Women in Wearables. Entrepreneur in Residence at NYSERDA. 7 healthcare patents. Engineering BSc & U. of Rochester Entrepreneurship & Management MS., Jared DwarikaCOO & Co-FounderDevice sales & manufacturing maven. 20 years industry experience. 10 healthcare patents allowed & 12 more pending. Grew sales by 30x to $5M at Western Scientific. Featured speaker at MEDICA - world’s #1 medical device event. Henley Business School MBA., Jennifer ChambersChief Medical Officer, MD MBA FACPClinical expert. Ex-Medical Director at Capital Blue Cross. Board-certified in Internal Medicine and Hospice & Palliative Medicine. Academic Development Committee Chair of the Penn State Harrisburg Board of Advisors. Penn State MD & MBA., Cameron Jacox Chief Growth OfficerGrowth maestro. Former Chief Growth Officer at Lark Health. Scaled AI chronic disease platform to $1B+. Former executive at exited startups MyFinance, NarrativeDx, & Vincere Health. Babson College Business Management BS.